
|Articles|April 1, 2002
Manufacturer, FDA revise isotretinoin labeling
Dermatologists and other isotretinoin (Accutane) prescribers soon will be mailed a new brochure on how to recognize psychiatric disorders in the pediatric population.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Envudeucitinib Shows Durable Skin Clearance in Phase 3 Psoriasis Extension
2
The Emerging Role of Oral Peptide Therapeutics in Psoriasis and Beyond
3
Social Media Mythbusters: Hydrocolloid Pimple Patches
4
Common Mistakes in Managing Hair Loss and Pigmentary Disorders
5










